Allo HSCT Using RIC and PTCy for Hematological Diseases

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Myelogenous Leukemia · Acute Lymphocytic Leukemia · Biphenotypic Acute Leukemia · Undifferentiated Leukemia · Prolymphocytic Leukemia · Chronic Myelogenous Leukemia · Plasma Cell Leukemia · Myelodysplastic Syndromes · Leukemia, Myeloid · Myelodysplastic Syndrome With Excess Blasts-1 · Burkitt Lymphoma · Relapsed T-Cell Lymphoma · Relapsed Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Marginal Zone Lymphoma · Follicular Lymphoma · Myeloproliferative Neoplasm · Myelofibrosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Mark Juckett)
Study leads
  • Mark Juckett

    Principal Investigator

    Masonic Cancer Center, University of Minnesota